Biochemistry, Genetics and Molecular Biology
BRCA1
100%
BRCA2
94%
Genetic Screening
63%
Genotyping
44%
Preimplantation
40%
Germ Cell
37%
Genetics
37%
Germline
34%
Hepatitis B Virus
32%
Methylation
29%
Prevalence
26%
DNA Mismatch Repair
25%
PMS2
21%
DNA Methylation
21%
Exon
20%
Estrogen Receptor
19%
Autosomal Dominant Inheritance
18%
MSH2
18%
Exome Sequencing
18%
Missense
17%
Genetic Disorder
17%
Cross Sectional Study
17%
Hepatitis C Virus
16%
Cohort Study
16%
Single-Nucleotide Polymorphism
15%
Aneuploidy
15%
Pribnow Box
14%
Promoter Region
13%
Familial Hypercholesterolemia
13%
Mitochondrial Disease
13%
Human Immunodeficiency Virus
13%
Penetrance
13%
Population
13%
Polymerase Chain Reaction
13%
Prospective Study
10%
Genetic Divergence
10%
Trophoblast
10%
Allele
10%
Autosomal Recessive Inheritance
10%
DNA Extraction
10%
Cystic Fibrosis
10%
Overall Survival
9%
MLH1
9%
Metabolomics
9%
Colon
9%
Metabolome
9%
Case-Control Study
8%
MSH6
8%
Genome-Wide Association Study
8%
Pedigree
8%
Adenosine Monophosphate
8%
Metabolite
8%
Quantitative Technique
8%
Candidate Gene
8%
Clinical Trial
7%
Proband
7%
Next Generation Sequencing
7%
RNA
7%
Genome Sequencing
6%
Exome
6%
Long Noncoding RNA
6%
Mental Retardation
6%
Copy-Number Variation
6%
Cancer Cell
6%
Protease Inhibitor
6%
Human Immunodeficiency Virus 1
6%
Chromosome 11
6%
Polyacrylamide Gel Electrophoresis
6%
Hepatitis B Virus Genotype D
6%
Consanguinity
6%
SCO1
6%
FCGR3B
6%
Nucleic Acid
6%
Coronavirinae
6%
Neutralizing Antibody
6%
Tumor Gene
6%
Loss of Heterozygosity
6%
Mutated Genes
6%
Interleukin 6
6%
Monocyte
6%
Doxorubicin
6%
Expression Quantitative Trait Loci
6%
Microsatellite Instability
6%
Dysplasia
6%
Fusion Transcript
6%
Amylase Blood Level
6%
Real-Time Polymerase Chain Reaction
6%
Endothelin 1
6%
Solution and Solubility
6%
Phosphate Blood Level
6%
Fatty Acid-Binding Protein
6%
DNA Extraction
6%
Secreted Frizzled-Related Protein 1
6%
Immunosurveillance
6%
Transcriptome
6%
Prenatal Screening
6%
Sensitization
6%
Life Expectancy
6%
Cancer Incidence
6%
Chorion Villus
6%
Medicine and Dentistry
Cancer Risk
50%
BRCA1
48%
Prevalence
44%
Neoplasm
38%
Chronic Hepatitis B
36%
BRCA2
35%
Breast Cancer
35%
Diseases
33%
Biological Marker
32%
Promoter Region
31%
Chronic Hepatitis C
28%
Genetic Screening
28%
Malignant Neoplasm
27%
Pancreas Adenocarcinoma
27%
Hereditary Nonpolyposis Colorectal Cancer
27%
Hepatocellular Carcinoma
26%
Hepatitis C
26%
Ovarian Cancer
25%
Hepatitis C Virus
24%
DNA Mismatch Repair
23%
Colorectal Cancer
22%
Cell-Free DNA
21%
Cross Sectional Study
21%
Hepatitis B Virus
20%
Human Immunodeficiency Virus
20%
Infection
19%
Liver Cirrhosis
16%
Diagnosis
16%
Cohort Analysis
15%
Prostate Cancer
15%
Systematic Review
14%
Personalized Medicine
13%
Krukenberg Tumor
13%
Diffuse Large B-Cell Lymphoma
13%
Hysterectomy
13%
Endometrial Cancer
12%
Exome Sequencing
12%
Cancer Staging
11%
Decompensated Liver Cirrhosis
11%
Estrogen Receptor Negative Breast Cancer
11%
Secreted Frizzled-Related Protein 1
11%
Population
10%
Estrogen Receptor
10%
Hepatitis B
10%
Hazard Ratio
9%
Genome Wide Association Study
9%
Prenatal Screening
9%
Gene Expression
9%
Breast Tissue
9%
Odds Ratio
8%
Mortality Rate
8%
Penetrance
8%
Counseling
7%
DNA Methylation
7%
Autosomal Dominant Inheritance
7%
Gemcitabine
7%
Clinical Genetics
7%
Retrospective Cohort Study
7%
Liver Cancer
7%
Clinical Trial
7%
Proportional Hazards Model
6%
Genetic Disorder
6%
Bilirubin
6%
Multiple Endocrine Neoplasia Type I
6%
Trisomy 21
6%
Isotopes of Calcium
6%
Oncology
6%
Blood Pressure
6%
Adolescent
6%
Randomized Controlled Trial
6%
Blood Glucose
6%
Proteinase Inhibitor
6%
Sympathetic Nervous System
6%
Postoperative Pain
6%
Hospital Care
6%
Atherosclerosis
6%
Bilirubin Glucuronide
6%
Mental Disorder
6%
Brain Tumor
6%
Drusen
6%
Radiation Therapy
6%
Chromosome Aberration
6%
Ischemic Heart Disease
6%
Doxorubicin
6%
Protein P53
6%
Familial Hypercholesterolemia
6%
Lactic Acid
6%
Transcriptome
6%
Diagnosis of Chronic Pancreatitis
6%
Breast Tumor
6%
Long Untranslated RNA
6%
English (Language)
6%
Cancer Cell
6%
Homologous Recombination
6%
Nonnucleoside Reverse Transcriptase Inhibitor
6%
Gene Linkage
6%
Simpson Golabi Behmel Syndrome
6%
Head and Neck Squamous Cell Carcinoma
6%
Severe Acute Respiratory Syndrome Coronavirus 2
6%
Trophoblast
6%
Keyphrases
SFRP1
14%
Pancreatic Adenocarcinoma
14%
Lynch Syndrome
13%
Gene Age
13%
Mismatch Repair
13%
Promoter Methylation
13%
Pathogenic Variants
9%
Blood Biomarkers
9%
Cancer Risk
8%
Denmark
7%
Gemcitabine
7%
Diglucuronide
6%
Protein-truncating Variants
6%
CABP2
6%
Genetic Network
6%
Liver
6%
New Human Leukocyte Antigen Allele
6%
Differential Allelic Expression
6%
Cardiovascular Disease
6%
Lactase Persistence
6%
Healthy Males
6%
IP-10
6%
Immune Surveillance
6%
Monocyte Phenotype
6%
Mutational Landscape
6%
CMV DNA
6%
Cancer Continuum
6%
QuantiFERON
6%
Homozygous Familial Hypercholesterolemia (HoFH)
6%
Pancreatic Ductal Adenocarcinoma
6%
Clinical Genetics
6%
Life Expectancy
6%
Say-Barber-Biesecker-Young-Simpson Syndrome
6%
KAT6B
6%
Sustained Virological Response
6%
Chronic Hepatitis C
6%
Cancer Pathology
6%
Breast Cancer Risk
6%
Mitochondrial Disease
6%
SCO1
6%
Outcome Prediction Model
6%
Inuit
6%
Late-stage Cancer
6%
Noninvasive Prenatal Testing
6%
Clinical Target Volume
6%
Aneuploidy Screening
6%
Cell Perturbation
6%
Cirrhosis
6%
Aneuploidy
6%
Pediatric Cancer
6%
Evolutionary Trace
6%
Amino Acid Starvation
6%
Germline Variation
6%
Disorder Potential
6%
Repeat Expansion Disorders
6%
Non-target Site
6%
Hypolactasia
6%
Preimplantation Genetic Testing for Aneuploidy (PGT-A)
6%
Prognostic Marker
6%
Hypofibrinogenemia
6%
TARS2
6%
Polygenic Risk Score
6%
Result Comparison
6%
KRAS Variant
6%
Rs61764370
6%
Expert Collaboration
6%
Nucleocapsid Protein
6%
Hepatitis C Virus Prevalence
6%
DNA Promoter Hypermethylation
6%
Deficiency Detection
6%
Methylation Markers
6%
Male Adults
6%
SARS-CoV-2 Lineages
6%
Lineage B.1.1.7
6%
External Validation Study
6%
Prostate Cancer Aggressiveness
6%
UNAIDS 90-90-90 Targets
6%
HIV Care Continuum
6%
Medical Geneticist
6%
Clinical Exome Sequencing
6%
Circumpolar Arctic
6%
PIONA
6%
HIV-1 Treatment
6%
Prognostic Efficacy
6%
Doyne Honeycomb Retinal Dystrophy
6%
Autosomal Dominant Drusen
6%
Malattia Leventinese
6%
Surgical Manipulation
6%
Local Area Networks
6%
Calcium Deposition
6%
TARP Syndrome
6%
Obesity
6%
Jean Genet
6%
Clinical Variants
6%
Variant Pathogenicity
6%
Cascade of Care
6%
WHO Targets
6%
BRCA-associated Breast Cancer
6%
Clinical Characterization
6%
Non-mucinous
6%